X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1168) 1168
animals (927) 927
raclopride (926) 926
humans (803) 803
neurosciences (778) 778
receptors, dopamine d2 - metabolism (594) 594
dopamine (590) 590
rats (574) 574
female (522) 522
dopamine - metabolism (510) 510
adult (487) 487
positron emission tomography (469) 469
index medicus (449) 449
corpus striatum - metabolism (413) 413
pet (390) 390
brain - metabolism (359) 359
dopamine antagonists - pharmacology (316) 316
tomography, emission-computed (308) 308
positron-emission-tomography (297) 297
middle aged (295) 295
c-11 raclopride (287) 287
raclopride - pharmacology (282) 282
brain - diagnostic imaging (273) 273
pharmacology & pharmacy (269) 269
rats, sprague-dawley (267) 267
positron-emission tomography (261) 261
psychiatry (260) 260
corpus striatum - diagnostic imaging (253) 253
brain (249) 249
carbon radioisotopes (239) 239
dose-response relationship, drug (214) 214
corpus striatum - drug effects (211) 211
raclopride - metabolism (204) 204
binding (198) 198
receptors (197) 197
receptors, dopamine - metabolism (185) 185
schizophrenia (182) 182
raclopride - pharmacokinetics (181) 181
dopamine antagonists (175) 175
dopamine d2 receptor antagonists (173) 173
benzazepines - pharmacology (172) 172
in-vivo (172) 172
salicylamides - pharmacology (171) 171
receptors, dopamine d2 - drug effects (169) 169
positron-emission tomography - methods (166) 166
salicylamides - metabolism (166) 166
dopamine receptors (162) 162
striatum (162) 162
dopamine antagonists - metabolism (161) 161
radiology, nuclear medicine & medical imaging (157) 157
aged (155) 155
brain - drug effects (155) 155
nucleus-accumbens (152) 152
clinical neurology (143) 143
mice (135) 135
receptor (134) 134
parkinsons-disease (133) 133
kinetics (130) 130
dopamine antagonists - pharmacokinetics (127) 127
basal ganglia (126) 126
microdialysis (122) 122
time factors (121) 121
phenols (120) 120
human-brain (117) 117
radioligand assay (117) 117
amphetamine (116) 116
article (116) 116
receptors, dopamine d1 - metabolism (114) 114
rat-brain (112) 112
neostriatum - metabolism (110) 110
release (108) 108
dopamine agonists - pharmacology (107) 107
autoradiography (106) 106
reward (106) 106
magnetic resonance imaging (104) 104
rat (104) 104
antipsychotic agents - pharmacology (102) 102
ligands (102) 102
rats, wistar (101) 101
putamen - metabolism (100) 100
brain mapping (99) 99
parkinson's disease (98) 98
receptors, dopamine - drug effects (96) 96
cocaine (95) 95
endogenous dopamine (93) 93
prefrontal cortex (92) 92
dopamine d2 receptors (90) 90
neuroimaging (87) 87
young adult (87) 87
analysis of variance (86) 86
haloperidol - pharmacology (84) 84
schizophrenia - metabolism (84) 84
dopamine d (83) 83
parkinson disease - diagnostic imaging (83) 83
amphetamine - pharmacology (82) 82
biochemistry & molecular biology (82) 82
caudate nucleus - metabolism (82) 82
dopamine uptake inhibitors - pharmacology (81) 81
binding, competitive (80) 80
nucleus accumbens - metabolism (78) 78
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 11/2007, Volume 130, Issue 11, pp. 2858 - 2867
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 04/2008, Volume 105, Issue 1, pp. 78 - 90
Journal Article
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 03/2009, Volume 301, Issue 11, pp. 1148 - 1154
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2011, Volume 6, Issue 12, p. e28946
Single large doses of methamphetamine ( METH) cause endoplasmic reticulum ( ER) stress and mitochondrial dysfunctions in rodent striata. The dopamine D-1... 
INDUCED NEURONAL APOPTOSIS | UNFOLDED-PROTEIN RESPONSE | MESSENGER-RNA | HYBRIDIZATION HISTOCHEMISTRY | INDUCED HYPERTHERMIA | BIOLOGY | INDUCED NEUROTOXICITY | RAT-BRAIN | HEAT-SHOCK-PROTEIN | CELL-DEATH | TRANSGENIC MICE | Fever - metabolism | Male | Endoplasmic Reticulum Stress - genetics | RNA, Messenger - metabolism | Receptors, Dopamine D2 - metabolism | Receptors, Dopamine D1 - metabolism | Mitochondria - genetics | Neostriatum - drug effects | Time Factors | Neostriatum - metabolism | Raclopride - pharmacology | Stress, Physiological - drug effects | Fever - pathology | Biomarkers - metabolism | Methamphetamine - pharmacology | HSP40 Heat-Shock Proteins - metabolism | Endoplasmic Reticulum Stress - drug effects | Stress, Physiological - genetics | Heat-Shock Proteins - metabolism | RNA, Messenger - genetics | Rats | Mitochondria - metabolism | Benzazepines - pharmacology | Mitochondria - drug effects | Rats, Sprague-Dawley | HSP70 Heat-Shock Proteins - metabolism | Up-Regulation - drug effects | Animals | Methamphetamine - administration & dosage | Cytochrome c | Proteins | Dopamine | Genes | Methamphetamine | Phenols | Heat shock proteins | Dopamine receptors | Cytochrome | Bax protein | Bcl-2 protein | Caspase-12 | Gene regulation | Activation | Kinases | Receptors | Mitochondria | Pathways | Methamphetamines | Rodents | Animal tissues | Neostriatum | Dopamine D2 receptors | Raclopride | Activating transcription factor 3 | GADD34 protein | Caspase | Gene expression | Stress | Studies | Polymerase chain reaction | Dopamine D1 receptors | Stress proteins | Endoplasmic reticulum | CHOP protein | Apoptosis | Heat shock
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 05/2005, Volume 515, Issue 1-3, pp. 10 - 19
Aripiprazole is the first clinically approved atypical antipsychotic agent having dopamine D2 receptor partial agonist activities. To evaluate aripiprazole's... 
Schizophrenia | Partial agonist | Antipsychotic | Receptor density | Dopamine D2 receptor | Aripiprazole | ANTAGONIST | SUBTYPES | DIFFERENTIAL ACTIONS | MONOAMINERGIC RECEPTOR | ANTIPARKINSON AGENTS | schizophrenia | OCCUPANCY | partial agonist | dopamine D2 receptor | MULTIPLE CLASSES | OPC-14597 | aripiprazole | PHARMACOLOGY & PHARMACY | antipsychotic | receptor density | Cricetulus | Humans | DNA, Complementary - genetics | Raclopride - metabolism | Piperazines - metabolism | Tritium | Lisuride - pharmacology | Quinolones - pharmacology | Receptors, Dopamine D2 - metabolism | Lisuride - analogs & derivatives | Transfection | Piperidines - pharmacology | Haloperidol - metabolism | Dopamine Antagonists - metabolism | Cell Membrane - metabolism | Radioligand Assay | Cyclic AMP - metabolism | Dopamine Agonists - metabolism | Haloperidol - pharmacology | Cell Membrane - drug effects | Dopamine - metabolism | CHO Cells | Dopamine Agonists - pharmacology | Cricetinae | Colforsin - pharmacology | Piperidines - metabolism | Dopamine - pharmacology | Quinolones - metabolism | Risperidone - pharmacology | Piperazines - pharmacology | Receptors, Dopamine D2 - genetics | Binding, Competitive - drug effects | Animals | Dopamine Antagonists - pharmacology | Lisuride - metabolism | Antipsychotic Agents - metabolism | Risperidone - metabolism | Antipsychotic Agents - pharmacology | Phenols
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 05/2006, Volume 97, Issue 4, pp. 1089 - 1103
Journal Article
Human Brain Mapping, ISSN 1065-9471, 04/2008, Volume 29, Issue 4, pp. 400 - 410
Journal Article
Journal Article